Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Joint involvement in AL amyloidosis].

P Blanco1, J F Viallard, B Bonotto

  • 1Service de Médecine Interne et Maladies Infectieuses, Centre François-Magendie, Hôpital du Haut-Lévêque, Pessac.

Annales De Medecine Interne
|October 16, 1999
PubMed
Summary

AL amyloid arthropathy affects 2-5% of patients, presenting as chronic, symmetrical joint pain. Diagnosis involves synovial fluid analysis and screening for monoclonal gammopathies, with synovectomy offering symptomatic relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases.

European journal of haematology·2024
Same author

Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.

Thrombosis research·2024
Same author

Hydropneumothorax diagnosed by lung ultrasound in a COVID-19 patient.

Medicina intensiva·2023
Same author

La Revue de medecine interne·2023
Same author

The midline venous catheter in critically ill COVID-19 patients.

Medicina intensiva·2022
Same author

Wine yeast selection in the Iberian Peninsula: <i>Saccharomyces</i> and non-<i>Saccharomyces</i> as drivers of innovation in Spanish and Portuguese wine industries.

Critical reviews in food science and nutrition·2022

Area of Science:

  • Rheumatology
  • Hematology
  • Pathology

Context:

  • AL amyloid arthropathy is a rare manifestation of plasma cell dyscrasias.
  • Understanding its presentation and management is crucial for patient outcomes.

Purpose:

  • To define the frequency, clinical, biological, and radiological presentation of AL amyloid arthropathy.
  • To outline current therapeutic options and highlight areas for future research.

Summary:

  • AL amyloid arthropathy occurs in 2-5% of cases, typically presenting as chronic, symmetrical polyarthritis, predominantly affecting upper limb joints.
  • Associated neurologic and cutaneous symptoms are common.
  • Synovial fluid analysis is key for diagnosis, alongside screening for monoclonal gammopathies. Synovectomy is the primary symptomatic treatment.

Related Experiment Videos

Impact:

  • Improved diagnostic strategies through synovial fluid analysis and monoclonal gammopathy screening.
  • Enhanced symptomatic management via synovectomy.
  • Future therapeutic advancements may arise from a deeper understanding of amyloid deposit pathogenesis.